封面
市場調查報告書
商品編碼
2052920

腎臟去神經裝置市場:依手術類型、最終用戶和地區分類

Renal Denervation Devices Market, By Procedure Type, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 138 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年腎臟去神經裝置市場規模估計為14.402億美元,預計2033年將達到38.076億美元。預計從2026年到2033年,其複合年成長率將達到14.9%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 14.402億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 14.90% 2033年市場規模預測: 38.076億美元

腎臟神經阻斷術是一種微創治療方法,旨在降低腎臟的交感神經活性。在治療方法中,醫師會將導管經動脈插入,到達腎動脈(供應腎臟的動脈)。然後,透過裝置將能量傳遞至血管壁上的神經,阻斷可能導致高血壓的訊號。能量傳遞可透過多種方法實現,包括射頻消融術和超音波。近年來,也開始採用直接藥物注射和經皮給藥系統等新調查方法。腎臟神經阻斷術的理論基礎是腎臟在血壓調節中扮演至關重要的角色。腎神經過度活躍會導致全身血壓升高。透過阻斷這些過度活躍的神經通路,腎臟神經阻斷術有望為其他治療方法無效的患者提供持續的血壓降低。雖然該手術在最初的臨床試驗中顯示出令人鼓舞的結果,但後續研究顯示結果存在差異,因此需要進一步研究以更好地了解哪些患者群體能夠從中獲益並最佳化該技術。儘管如此,該設備的研發仍在繼續,目前正在進行臨床試驗以評估其安全性和有效性。

市場動態

預計2026年至2033年期間,腎臟去神經裝置市場將顯著成長。高血壓盛行率的上升等多種因素正在推動這一市場成長。此外,創新產品核准的增加預計也將促進預測期內的市場成長。例如,醫療設備製造商Kalos Medical獲得了467萬韓元(約350萬美元)的津貼,用於推進一種治療高血壓的腎臟去神經醫療設備的研究。

本研究的關鍵特徵

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 根據公司亮點、產品系列、主要特點、財務表現和策略等參數,創建全球腎臟去神經裝置市場主要參與者的概況。
  • 本研究涵蓋的主要公司包括美敦力、Recor Medical, Inc.、波士頓科學公司、Kona Medical、泰爾茂株式會社、雅培和消融解決方案公司。
  • 本報告中的見解將使企業負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球腎臟去神經裝置市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等各行業相關人員。
  • 相關人員可以透過分析全球腎臟去神經裝置市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球腎臟去神經裝置市場:依手術類型分類,2021-2033年

  • 經皮腎去神經術
  • 射頻腎切除術
  • 腎臟去神經超音波超音波
  • 其他

第5章 全球腎臟去神經裝置市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第6章 全球腎臟去神經裝置市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • ASEAN
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 中非
    • 北非

第7章 競爭情勢

  • Medtronic
  • Recor Medical, Inc.
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • 其他

第8章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI798

Renal Denervation Devices Market is estimated to be valued at USD 1,440.2 Mn in 2026 and is expected to reach USD 3,807.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 1,440.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 14.90% 2033 Value Projection: USD 3,807.6 Mn

Renal denervation is a minimally invasive procedure that aims to decrease the sympathetic nerve activity to the kidneys. It involves threading a catheter through the arteries until it reaches the renal arteries, which supplies blood to the kidneys. The device then delivers energy to the nerves in the vessel wall to disrupt the signals that can cause high blood pressure. The energy can be delivered through various methods, such as radiofrequency ablation, ultrasound, and more recently, direct injection of chemicals or new methodologies based on percutaneous delivery systems. The rationale behind renal denervation comes from the understanding that the kidneys play a significant role in blood pressure regulation. Overactive renal nerves can lead to increased systemic blood pressure. By disrupting these overactive nerve pathways, renal denervation can potentially help to sustainably lower blood pressure in people for whom other treatments have failed. Although the procedure showed promise in early clinical trials, some subsequent trials had mixed results, which led to further investigations to better understand the patient populations that may benefit and to optimize the technique. Nonetheless, the devices continue to be studied and developed, with ongoing clinical trials evaluating their safety and efficacy.

Market Dynamics

The renal denervation devices market is expected to witness significant growth during the forecast period 2026 - 2033. Several factors contribute to the market growth including the rising prevalence of hypertension. Additionally, the increasing approval of innovative products is expected to propel the market growth over the forecast period. For instance, Kalos Medical, a medical device company, received a grant of Won4.67m (approximately $3.5m) to advance the development of its renal denervation medical device to treat hypertension.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key players in the global renal denervation devices market are profiled based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies
  • Key companies covered in this study include Medtronic, Recor Medical, Inc., Boston Scientific Corp, Kona Medical, Terumo Corporation, Abbott, Ablative Solutions, and others
  • Insights from this report would enable marketers and management authorities of companies to make informed decisions regarding future product launches, product upgrades, market expansion, and marketing tactics.
  • The global renal denervation devices market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global renal denervation devices market

Market Segmentation

  • Procedure Type Insights (Revenue, USD Million, 2021 - 2033)
  • Percutaneous Renal Denervation
  • Radiofrequency Renal Denervation
  • Ultrasound Renal Denervation
  • Others
  • End User Insights (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Others
  • Regional Insights (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Medtronic
  • Recor Medical, Inc.
  • Boston Scientific Corp
  • Kona Medical
  • Terumo Corporation
  • Abbott
  • Ablative Solutions
  • Others

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Renal Denervation Devices Market, By Procedure Type, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Percutaneous Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Radiofrequency Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Ultrasound Renal Denervation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)

5. Global Renal Denervation Devices Market, By End User, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Million)

6. Global Renal Denervation Devices Market, By Region, 2021 - 2033, (USD Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
      • China
      • Japan
      • India
      • Australia
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure Type, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Million)
      • South Africa
      • Central Africa
      • North Africa

7. Competitive Landscape

  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Recor Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boston Scientific Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kona Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ablative Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us